Alkem Lab Q4 PAT slumps 25% YoY to Rs 251 cr

As reported by Markets

Alkem Laboratories reported 25.11% drop in consolidated net profit to Rs 251.11 crore despite 14.62% jump in revenue from operations to Rs 3603.32 crore in Q4 March 2026 over Q4 March 2025.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Markets ↗

Market Samachar is a news aggregator. This article was originally published by Markets. Tap the button above to read the full story on their site.

INDIAN Pharma stock declares 18% final dividend along with Q4 results 2026 mint - markets
INDIAN Gold rate today: MCX gold prices tank over ₹2,000 to below ₹1,54000 as fresh US-Iran tensions raise inflation woes mint - markets
INDIAN US stock market today: Dow Jones, Nasdaq slip as Middle East tensions intensify; Brent crude rebounds mint - markets
INDIAN US Stock Market Today Live Updates: US stocks edge marginally lower; traders assess inflation data, Mideast developments mint - markets
INDIAN US stocks today: US stocks hold near records even as crude oil prices rise again Markets-Economic Times
INDIAN US jobless claims rise to 215,000 but layoffs remain low despite Iran war uncertainty Markets-Economic Times
INDIAN Quote of the day by Robert Wilson: "The only way one makes money in the market is when the market’s perception of a stock changes" Markets-Economic Times
INDIAN Power stocks surge on strong order books, demand outlook and earnings Markets

Alkem Lab Q4 PAT slumps 25% YoY to Rs 251 cr

More from Market Samachar